Publications
In vitro discovery of novel prokaryotic ion channel candidates for antiarrhythmic gene therapy.. Vol. 654., 2021.
Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium." Acta biomaterialia 126 (2021): 144-153.
"Neuromuscular Development and Disease: Learning From in vitro and in vivo Models." Frontiers in cell and developmental biology 9 (2021).
"The NIH Somatic Cell Genome Editing program." Nature 592, no. 7853 (2021): 195-204.
"Single Vector AAV Approach to Genome Editing in Pompe Disease." In MOLECULAR THERAPY, 291. Vol. 29. 2021.
"Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease." Commun Biol 4, no. 1 (2021).
" "
BRG1 is a biomarker of hypertrophic cardiomyopathy in human heart specimens." Sci Rep 12, no. 1 (2022).
"CRISPR Library Screening in Cultured Cardiomyocytes." Methods in molecular biology (Clifton, N.J.) 2485 (2022): 1-13.
"Differential microRNA profiles of intramuscular and secreted extracellular vesicles in human tissue-engineered muscle." Front Physiol 13 (2022).
"Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy." Nat Commun 13, no. 1 (2022).
"Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction." Cell stem cell 29, no. 2 (2022): 281-297.e12.
"Meteorin-like is an injectable peptide that can enhance regeneration in aged muscle through immune-driven fibro/adipogenic progenitor signaling." Nat Commun 13, no. 1 (2022).
"Myoblast deactivation within engineered human skeletal muscle creates a transcriptionally heterogeneous population of quiescent satellite-like cells." Biomaterials 284 (2022): 121508.
"Targeted Delivery for Cardiac Regeneration: Comparison of Intra-coronary Infusion and Intra-myocardial Injection in Porcine Hearts." Front Cardiovasc Med 9 (2022).
"Toward improved understanding of cardiac development and congenital heart disease: The advent of cardiac organoids." J Thorac Cardiovasc Surg 164, no. 6 (2022): 2013-2018.
"Translating musculoskeletal bioengineering into tissue regeneration therapies." Science translational medicine 14, no. 666 (2022).
"Author Correction: Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy." Nat Commun 14, no. 1 (2023).
"Conserved chamber-specific polyploidy maintains heart function in Drosophila." Development 150, no. 16 (2023).
"Differential Response of Engineered Human Cardiac Tissues to Delta and Omicron COVID-19 Virus." J Am Heart Assoc 12, no. 12 (2023).
"An enhancer-based gene-therapy strategy for spatiotemporal control of cargoes during tissue repair." Cell Stem Cell 30, no. 1 (2023): 96-111.e6.
"Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney disease." Res Sq (2023).
"Prokaryotic voltage-gated sodium channels are more effective than endogenous Nav1.5 channels in rescuing cardiac action potential conduction: an in silico study." American journal of physiology. Heart and circulatory physiology 325, no. 5 (2023): H1178-H1192.
"Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium." Science advances 10, no. 4 (2024).
"